The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults

被引:185
作者
Fenton, CL
Lukes, Y
Nicholson, D
Dinauer, CA
Francis, GL
Tuttle, RM
机构
[1] Mem Sloan Kettering Canc Ctr, Endocrine Serv, New York, NY 10021 USA
[2] Walter Reed Army Med Ctr, Dept Pediat, Washington, DC 20307 USA
[3] Walter Reed Army Med Ctr, Dept Clin Invest, Washington, DC 20307 USA
[4] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Bethesda, MD 20814 USA
[5] Mem Sloan Kettering Canc Ctr, Endocrine Serv, New York, NY 10021 USA
关键词
D O I
10.1210/jc.85.3.1170
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The ret/PTC rearrangements (PTC-1, PTC-3, and PTC-3) are characteristic of papillary thyroid cancer (PTC). In adults, PTC-1 is common and may be associated with an aggressive clinical course. The incidence and significance of ret/PTC mutations are less well understood in children. We examined spontaneous PTC from 33 patients (23 females and 10 males) with a median age of 18 yr (range, 6-21 yr) and a median follow-up of 3.5 yr (range, 0-13.4 yr). The ret/PTC mutations were identified in 15 tumors (45%), including 8 PTC-1 (8 of 15, 53%), 2 PTC-P (2 of 15, 13%), 2 PTC-3 (2 of 15, 13%), and 3 13 df 15, 20%) combined PTC mutations (PTC-1 and PTC-P). This distribution is significantly different (P = 0.001, by chi(2) analysis) from that reported for children with radiation-induced PTC. There was no correlation between the presence or type of ret/PTC mutation and patient age, tumor size, focality, extent of disease at diagnosis, or recurrence. We conclude that ret/PTC mutations are 1) common in sporadic childhood PTC, 2) predominantly PTC-1, 3) frequently multiple, and 4) of different distribution than that reported for children with radiation-induced PTC.
引用
收藏
页码:1170 / 1175
页数:6
相关论文
共 17 条
  • [1] Bongarzone I, 1998, CLIN CANCER RES, V4, P223
  • [2] Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma
    Bongarzone, I
    Fugazzola, L
    Vigneri, P
    Mariani, L
    Mondellini, P
    Pacini, F
    Basolo, F
    Pinchera, A
    Pilotti, S
    Pierotti, MA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (05) : 2006 - 2009
  • [3] NATURAL-HISTORY, TREATMENT, AND COURSE OF PAPILLARY THYROID-CARCINOMA
    DEGROOT, LJ
    KAPLAN, EL
    MCCORMICK, M
    STRAUS, FH
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (02) : 414 - 424
  • [4] Ret and trk proto-oncogene activation in thyroid papillary carcinomas in French patients from the Champagne-Ardenne region
    Delvincourt, C
    Patey, M
    Flament, JB
    Suarez, HG
    Larbre, H
    Jardillier, JC
    Delisle, MJ
    [J]. CLINICAL BIOCHEMISTRY, 1996, 29 (03) : 267 - 271
  • [5] Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults
    Dinauer, CAW
    Tuttle, RM
    Robie, DK
    McClellan, DR
    Svec, RL
    Adair, C
    Francis, GL
    [J]. CLINICAL ENDOCRINOLOGY, 1998, 49 (05) : 619 - 628
  • [6] FUGAZZOLA L, 1995, CANCER RES, V55, P5617
  • [7] Klugbauer S, 1995, ONCOGENE, V11, P2459
  • [8] RET/PTC and RET tyrosine kinase expression in adult papillary thyroid carcinomas
    Learoyd, DL
    Messina, M
    Zedenius, J
    Guinea, AI
    Delbridge, LW
    Robinson, BG
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (10) : 3631 - 3635
  • [9] High frequency of rearrangement of the RET protooncogene (RET/PTC) in Chinese papillary thyroid carcinomas
    Lee, CH
    Hsu, LS
    Chi, CW
    Chen, GD
    Yang, AH
    Chen, JY
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (05) : 1629 - 1632
  • [10] Mayr B, 1997, J CLIN ENDOCR METAB, V82, P1306, DOI 10.1210/jc.82.4.1306